Skip to main content

Johnson & Johnson gross margin

  • JNJ · NYSE
  • Healthcare
  • Pharmaceuticals
  • S&P 500
$285.75+0.79%Close 13 Nov 2026 · Market value $686.1B

Johnson & Johnson's gross margin was 67.9% for fiscal year 2025 (the twelve months to 28 Dec 2025), down 1.2 points from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 27 Sep 2026) it was 68.1%, down 1.4 points from a year earlier.

From Johnson & Johnson's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 21 Oct 2026.

Fiscal 2025
67.9%
−1.2 pts
Q3 FY2026
68.1%
−1.4 pts on a year
Average over 10 years
68.1%
FY 2016–FY 2025

Gross margin by fiscal year

69.7%FY 201666.7%FY 2017−3.0 pts66.8%FY 2018+0.1 pts66.4%FY 2019−0.4 pts65.6%FY 2020−0.8 pts70.3%FY 2021+4.7 pts69.3%FY 2022−1.0 pts68.8%FY 2023−0.4 pts69.1%FY 2024+0.3 pts67.9%FY 2025−1.2 pts

Change in points on the year before, under each year. From FY 2016 to FY 2025, Johnson & Johnson's gross margin went from 69.7% to 67.9%; the highest was 70.3% in FY 2021.

Johnson & Johnson gross margin, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Gross margin69.7%66.7%66.8%66.4%65.6%70.3%69.3%68.8%69.1%67.9%
Period end1 Jan 201731 Dec 201730 Dec 201829 Dec 20193 Jan 20212 Jan 20221 Jan 202331 Dec 202329 Dec 202428 Dec 2025

Gross margin by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Johnson & Johnson gross margin, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Gross margin68.3%66.4%67.9%69.6%67.6%66.3%68.2%68.1%
Period end29 Dec 202430 Mar 202529 Jun 202528 Sep 202528 Dec 202529 Mar 202628 Jun 202627 Sep 2026

How gross margin is measured

Gross margin is gross profit divided by revenue: the share of each dollar of sales left after the cost of what was sold. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Johnson & Johnson's other figures

Gross margin of comparable companies

Everything on JNJ, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.